Home Products Technology Publications About Contact Request Demo
Company Overview

About DiPath

Advancing cancer diagnostics through AI innovation

Company Overview

Pioneering the Future of Digital Pathology

Hangzhou DiPath Technology Co., Ltd. is a high-tech medical enterprise dedicated to advancing cancer diagnostics through the power of artificial intelligence and digital pathology.

With over 20 years of combined expertise in AI technology and digital pathology, we have established ourselves as a leader in the field, providing comprehensive solutions from slide scanning to AI-assisted diagnosis.

Our complete product portfolio encompasses the entire pathology workflow, enabling healthcare institutions worldwide to deliver faster, more accurate diagnoses and ultimately improve patient outcomes.

CE-IVD Certified
NMPA Approved
ISO 13485
0

Registration Certificates

0

Intelligent Analysis Modules

0

Invention Patents

0

Cooperative Hospitals

Our Journey

Our Story

From our founding to becoming a global leader in AI-powered pathology

2017
Company Founded
DiPath was established in Hangzhou, China, with a vision to revolutionize cancer diagnostics through AI and digital pathology technology.
2018
First Product Launch
Launched our first AI-powered pathology analysis module, marking the beginning of our comprehensive product portfolio.
2019
NMPA Certifications
Received first NMPA (National Medical Products Administration) approvals for our diagnostic AI modules.
2020
International Expansion
Established partnerships with leading pharmaceutical companies and expanded into international markets.
2021
CE-IVD Certification
Achieved CE-IVD certification for European market entry, meeting the highest international standards.
2023
200+ Publications Milestone
Surpassed 200 SCI publications, demonstrating our commitment to scientific excellence and research collaboration.
2024
Global Leadership
Partnered with nearly 1500 hospitals worldwide and continued to expand our global footprint in digital pathology.
0
Years of Excellence
Leading innovation in AI pathology
Leadership

Meet Our Team

Visionary leaders driving innovation in digital pathology

Dr. Lin Yang

Dr. Lin Yang

Founder & CEO

Former tenured professor at University of Florida. Ph.D. from Rutgers University. Published 100+ papers in Nature Machine Intelligence, Nature Medicine, CVPR, MICCAI. Google Scholar Citations: 9736, H-index 50.

Dr. Yefeng Zheng

Dr. Yefeng Zheng

Chief Scientist

IEEE Fellow; AIMBE Fellow. Ph.D. in Electrical and Computer Engineering from University of Maryland. Former Tencent Distinguished Scientist and Director of Jarvis Laboratory. Google Scholar Citations: 32,700+, H-index 87.

Dr. Jun Feng

Dr. Jun Feng

Head of Intelligent Information Processing

Expert Reviewer for MOST, MOHRSS, MIIT, NSFC. PI of 10+ national projects. Head of Intelligent Information Processing Group at Northwest University, leads ~200 faculty & graduate researchers.

Dr. Kang Li

Dr. Kang Li

Co-founder & Director of Big Data Center

PhD advisor in Medical Engineering and Computer Science at a U.S. public Ivy League university. Pioneer and internationally recognized expert in AI/deep learning for medical imaging. Director of Big Data Center at West China Hospital.

Dr. Lei Cui

Dr. Lei Cui

Head of AI & Digital Pathology Lab

Vice Chair of CCF YOCSEF Xi'an. Standing Member of Pathology Committee at Shaanxi International Medical Exchange Association. Research focus on medical imaging, especially digital pathology analysis and applications.

Partnerships

Global Partners

Collaborating with industry leaders to advance pathology diagnostics worldwide

AstraZeneca
Takeda
Zeiss
Roche
Hologic

Pharma Research

Partnering with pharmaceutical leaders to accelerate drug discovery and biomarker development through AI-powered pathology analysis.

Technology Integration

Collaborating with microscopy and imaging technology leaders to deliver seamless, integrated pathology solutions.

Academic Collaboration

Working with top research institutions worldwide to advance the science of digital pathology and publish groundbreaking research.

Recognition

Awards & Certifications

Recognized for excellence in quality, innovation, and regulatory compliance

ISO 27001

Information Security Management System certification

Data Security

NMPA Approvals

20+ medical device registrations from National Medical Products Administration

Regulatory Approved

CE-IVD Certified

European In Vitro Diagnostic Device certification for EU market

EU Compliant

Be Part of the Future of Pathology

Join our team of innovators, researchers, and healthcare professionals dedicated to transforming cancer diagnostics through AI.